849239-19-6

Upstream product

• 6498-34-6 cyclohexylhydrazine 
• 849239-17-4 ethyl 1-cyclohexyl-5-(4-benzyloxyphenyl)-1H-pyrazole-3-carboxylate 
• 957794-57-9 C₁₉H₁₈O₅ 

Downstream Products

• 849239-20-9 methyl (2E)-3-{5-[4-(benzyloxy)phenyl]-1-cyclohexyl-1H-pyrazol-3-yl}-2-propenoate 
• 849239-28-7 ethyl (2E)-3-{5-[4-(benzyloxy)phenyl]-1-cyclohexyl-1H-pyrazol-3-yl}-2-methyl-2-propenoate 
• 1310458-88-8 C₃₆H₃₆N₄O₄ 
• 1310458-89-9 (E)-3-(2-(4-((4'-cyano-4-(4-hydroxypiperidine-1-carbonyl)biphenyl-2-yl)methoxy)phenyl)-1-cyclohexyl-1H-imidazol-4-yl)-2-methylacrylic acid 
• 1310458-87-7 C₃₅H₃₄N₄O₄ 
• 1310458-86-6 C₃₅H₃₆ClN₃O₅ 
• 1310459-04-1 C₃₉H₄₃N₃O₆S 
• 1310459-03-0 C₃₇H₄₁N₃O₅S 
• 1310459-02-9 C₃₆H₃₉N₃O₅S 
• 1310459-01-8 C₄₁H₄₄N₄O₅ 
• 1310459-00-7 C₃₈H₄₀N₄O₄ 
• 1310458-98-0 C₃₇H₃₈N₄O₄ 
• 1310458-97-9 C₃₇H₄₀ClN₃O₅ 
• 1310458-96-8 C₄₀H₄₄ClN₃O₅ 

Relevant academic research and scientific papers

The Synthesis and evaluation of a novel class of (E)-3-(1-cyclohexyl-1H- pyrazol-3-yl)-2-methylacrylic acid Hepatitis C virus polymerase NS5B inhibitors

Herein we report the identification and evaluation of a novel series of (E)-3-(1-cyclohexyl-1H-pyrazol-3-yl)-2-methylacrylic acid derivatives identified from a deannulation study performed on the reported benzimidazole NS5B inhibitor, 1. This resulted in